H.R. 4581 · 119th Congress · Health

340B PATIENTS Act of 2025

In committee1.3k words Introduced Jul 22, 2025 · Latest action Jul 22, 2025

How far it has goneStage 2 of 6
  1. IntroducedJul 22, 2025 Done
  2. CommitteeReferred to Energy and Commerce Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.

Who lobbies on it

10 organizations, more than 97% of House bills · 27 filings · Q3 2025–Q3 2026

These 10 organizations’ PACs gave $102K to 13 of the 22 members sponsoring or cosponsoring H.R. 4581 in the 2025–26 election cycle.

See who got it, from which PACs, and how they compare to the rest of the House → Pro

One square per quarter since introduction, oldest left. Filled = named H.R. 4581 or S. 2372 that quarter.

  1. American Hospital Association 5 of 5 quarters
    “H.R. 4581 / S.2372, 340B PATIENTS Act, all provisions; H.R. 5256, 340B Access Act, all provisions; DRAFT, 340B Drug Pricing Integrity and Affordability for Patients Act, all provisions; H.R. 9599, Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act), all…”

    $14.4M lobbying spend in 2026 to date, all issuesQ3 2026 filing · names both

  2. American Society of Health-System Pharmacists 5 of 5 quarters
    “…The 340B PATIENTS Act (H.R. 4581/S. 2372) and the SECURE 340B Act (H.R. 9599), issues related to 340B program nondiscrimination and contract pharmacy arrangements. [CN1.1] Issues related to drug price negotiations and patient out-of-pocket costs (generally, no specific legislation). Issues related to patient access to…”

    $750K lobbying spend in 2026 to date, all issuesQ3 2026 filing · names both

  3. Lundbeck Llc 4 of 5 quarters
    “Issues pertaining to the 340B Drug Discount Program - H.R. 5256, the 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025; H.R. 9504, Tax Exempt Hospital Transparency Act; S.5244, SUSTAIN 340B Act; H.R.9599, SECURE 340B Act Step therapy reform - H.R. 5509 & S. 2903, Safe Step Act Neuroscience Drug Program…”

    $440K lobbying spend in 2026 to date, all issuesQ3 2026 filing · names both

7 more organizations, every filingPROUpgrade

Organizations that named H.R. 4581 or its companion S. 2372 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Reports naming only S. 2372 are included and tagged. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Members sponsoring the companion, S. 2372, are counted on that bill’s page, not here. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

2 actions · newest first
  1. Jul 22, 2025Referred to the House Committee on Energy and Commerce.
  2. Jul 22, 2025Introduced in House